Table 2.
Study ID | Study design | Data analysis | Allocation generation | Allocation concealment | Blinding | Lost to follow-up | |
Tambour | 2018 | RCT | ITT | Adequate | Adequate | Assessor blinded | 5.2% at 7 mo |
Devoogdt | 2018 | RCT | ITT | Adequate | Adequate | Assessor blinded | 1.2% at 6 mo |
Zhang | 2016 | RCT | PP | Inadequate | Unclear | None reported | None |
Cho | 2016 | RCT | ITT | Inadequate | Unclear | Assessor blinded | 14.6% at 1 mo |
Bergmann | 2014 | RCT | ITT | Inadequate | Unclear | None reported | 13.6% at 24 d |
Ridner | 2013 | RCT | PP | Computer-generated | Unclear | None reported | None |
Zimmermann | 2012 | RCT | PP | Inadequate | Unclear | None reported | None |
Belmonte | 2012 | RCT | ITT | Computer-generated | Adequate | Assessor blinded | 11.1% at 2 mo |
Devoogdt | 2011 | RCT | ITT | Adequate | Adequate | Assessor blinded | 4% at 12 mo |
Szolnoky | 2009 | RCT | ITT | Unclear | Unclear | None reported | None |
Didem | 2005 | RCT | PP | Unmarked envelopes | Adequate | Patient blinded | 5.4% at 1 mo |
McNeely | 2004 | RCT | PP | Computer-generated code | Adequate | Assessor blinded | 11.1% at 1 mo |
Williams | 2002 | RCT | PP | Unclear | Unclear | None reported | 6.5% at 3 wk |
Sitzia | 2002 | RCT | PP | Computer-generated | Adequate | None reported | 3.6% at 2 wk |
Andersen | 2000 | RCT | ITT | Unclear | Unclear | None reported | 2.4 at 3 mo, 9.5% at 12 mo |
Johansson | 1999 | RCT | PP | Inadequate | Unclear | None reported | None |
Johansson | 1998 | RCT | PP | Unclear | Unclear | None reported | None |
ITT = intention-to-treat, PP = per-protocol, RCT = randomized controlled trial.